More importantly, protein levels of Me3-NFAT5 K668 and MGMT were remarkably decreased in GBM-24 tumors upon combination treatment, compared to TMZ treatment alone (Fig. 8j and Supplementary Fig. 12f). The gene discussed is MGMT; the disease is glioblastoma.